Literature DB >> 15336981

L-type Ca2+ channels in Ca2+ channelopathies.

Jörg Striessnig1, Jean-Charles Hoda, Alexandra Koschak, Francesca Zaghetto, Carmen Müllner, Martina J Sinnegger-Brauns, Claudia Wild, Katrin Watschinger, Alexander Trockenbacher, Gilda Pelster.   

Abstract

Voltage-gated L-type Ca2+ channels (LTCCs) mediate depolarization-induced Ca2+ entry in electrically excitable cells, including muscle cells, neurons, and endocrine and sensory cells. In this review we summarize the role of LTCCs for human diseases caused by genetic Ca2+ channel defects (channelopathies). LTCC dysfunction can result from structural aberrations within pore-forming alpha1 subunits causing incomplete congenital stationary night blindness, malignant hyperthermia sensitivity or hypokalemic periodic paralysis. However, studies in mice revealed that LTCC dysfunction also contributes to neurological symptoms in Ca2+ channelopathies affecting non-LTCCs, such as Ca(v)2.1 alpha1 in tottering mice. Ca2+ channelopathies provide exciting molecular tools to elucidate the contribution of different LTCC isoforms to human diseases. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336981     DOI: 10.1016/j.bbrc.2004.08.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia.

Authors:  Chris Peers; Jason L Scragg; John P Boyle; Ian M Fearon; Shafeena C Taylor; Kim N Green; Nicola J Webster; Martin Ramsden; Hugh A Pearson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium.

Authors:  Sönke Wimmers; Linn Coeppicus; Rita Rosenthal; Olaf Strauss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-13       Impact factor: 3.117

Review 3.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

4.  Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis.

Authors:  K Kageyama; K Terui; S Tsutaya; E Matsuda; M Shoji; S Sakihara; T Nigawara; S Takayasu; T Moriyama; M Yasujima; T Suda
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

Review 5.  Channeling studies in yeast: yeast as a model for channelopathies?

Authors:  Devin M Wolfe; David A Pearce
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  Regulation of voltage-gated calcium channels by proteolysis.

Authors:  Kathryn Abele; Jian Yang
Journal:  Sheng Li Xue Bao       Date:  2012-10-25

7.  Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation.

Authors:  Viktor Yarotskyy; Guofeng Gao; Lei Du; Sindura B Ganapathi; Blaise Z Peterson; Keith S Elmslie
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

Review 8.  [Human calcium channelopathies. Voltage-gated Ca(2+) channels in etiology, pathogenesis, and pharmacotherapy of neurologic disorders].

Authors:  M Weiergräber; J Hescheler; T Schneider
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

9.  Dynamic interplay of excitatory and inhibitory coupling modes of neuronal L-type calcium channels.

Authors:  Petra Geier; Michael Lagler; Stefan Boehm; Helmut Kubista
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-12       Impact factor: 4.249

Review 10.  Pore stability and gating in voltage-activated calcium channels.

Authors:  Steffen Hering; Stansilav Beyl; Anna Stary; Michaela Kudrnac; Annette Hohaus; H Robert Guy; Eugen Timin
Journal:  Channels (Austin)       Date:  2008-03-14       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.